|
1
|
Teicher BA: Hypoxia and drug resistance.
Cancer Metastasis Rev. 13:139–168. 1994.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Weinmann M, Belka C and Plasswilm L: Tumor
hypoxia: Impact on biology, prognosis and treatment of solid
malignant tumors. Oncology. 27:83–90. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang H, Jiang H, Van De Gucht M and De
Ridder M: Hypoxic Radioresistance: Can ROS be the key to overcome
it? Cancers (Basel). 11(112)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ogawa Y: Paradigm shift in radiation
biology/radiation oncology-exploitation of the
‘H2O2 Effect’ for radiotherapy using low-LET
(Linear Energy Transfer) radiation such as X-rays and high-energy
electrons. Cancers (Basel). 8(28)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nimalasena S, Gothard L, Anbalagan S,
Allen S, Sinnett V, Mohammed K, Kothari G, Musallam A, Lucy C, Yu
S, et al: Intratumoural hydrogen peroxide with radiotherapy in
locally advanced breast cancer: Results from a phase I clinical
trial. Int J Radiat Oncol Biol Phys. 108:1019–1029. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
KORTUC Phase II - Intra-tumoural radiation
sensitizer in patients with locally advanced/recurrent breast
cancer. https://clinicaltrials.gov/ct2/show/NCT03946202.
Accessed September 12, 2020.
|
|
7
|
Cervix Uteri. Global Cancer Observatory.
https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf.
Accessed March 1 2021.
|
|
8
|
CERV-6. NCCN Guidelines Version
1.2021Cervical CancerNCCN Evidence Blocks™. https://www.nccn.org/professionals/physician_gls/pdf/cervical_blocks.pdf.
Accessed March 1, 2021.
|
|
9
|
Banerjee R and Kamrava M: Brachytherapy in
the treatment of cervical cancer: A review. Int J Womens Health.
6:555–564. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Japanese Structure Survey of Radiation
Oncology in 2015 (First Report). https://www.jastro.or.jp/medicalpersonnel/data_center/cat6/cat/2015.html.
Accessed 12 September 2020.
|
|
11
|
Ogawa Y, Ue H, Tsuzuki K, Tadokoro M,
Miyatake K, Sasaki T, Yokota N, Hamada N, Kariya S, Hitomi J, et
al: New radiosensitization treatment (KORTUC I) using hydrogen
peroxide solution-soaked gauze bolus for unresectable and
superficially exposed neoplasms. Oncol Rep. 19:1389–1394.
2008.PubMed/NCBI
|
|
12
|
Ogawa Y, Kubota K, Ue H, Tadokoro M,
Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H,
et al: Safety and effectiveness of a new enzyme-targeting
radiosensitization treatment (KORTUC II) for intratumoral injection
for low-LET radioresistant tumors. Int J Oncol. 39:553–560.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Aoyama N, Ogawa Y, Yasuoka M, Takahasi M,
Iawasa H, Miyatake K, Yamanishi T, Hamada N, Tamura T, Kobayashi K,
et al: Therapeutic response to a novel enzyme-targeting
radiosensitization treatment (Kochi oxydol-radiation therapy for
unresectable carcinomas) in patients with recurrent breast cancer.
Oncol Lett. 12:29–34. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Aoyama N, Ogawa Y, Yasuoka M, Iwasa H,
Miyatake K, Yoshimatsu R, Yamanishi T, Hamada N, Tamura T,
Kobayashi K, et al: Therapeutic response to a novel
enzyme-targeting radiosensitization treatment (KORTUC II) for
residual lesions in patients with stage IV primary breast cancer,
following induction chemotherapy with epirubicin and
cyclophosphamide or taxane. Oncol Lett. 13:69–76. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nishioka A, Ogawa Y, Miyatake K, Tadokoro
M, Nogami M, Hamada N, Kubota K, Kariya S, Kohsaki T, Saibara T, et
al: Safety and efficacy of imageguided enzyme-targeting
radiosensitization and intraoperative radiotherapy for locally
advanced unresectable pancreatic cancer. Oncol Lett. 8:404–408.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ogawa Y, Kubota K, Aoyama N, Yamanishi T,
Kariya S, Hamada N, Nogami M, Nishioka A, Onogawa M and Miyamura M:
Non-surgical breast-conserving treatment (KORTUC-BCT) using a new
radiosensitization method (KORTUC II) for patients with stage I or
II breast cancer. Cancers (Basel). 7:2277–2289. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
3.2Mechanism of Causing Effects on Human
Body. BOOKLET to Provide Basic Information Regarding Health Effects
of Radiation (1st edition). Ministry of the Enviroment Government
of Japan. https://www.env.go.jp/en/chemi/rhm/basic-info/1st/
Assecced March 3, 2021.
|
|
18
|
Common Terminology Criteria for Adverse
Events (CTCAE) Version 4.0. National cancer institute. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_50.
Accessed September 12, 2020.
|
|
19
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schawartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
CERV-G. NCCN Guidelines Version
1.2021Cervical CancerNCCN Evidence BlocksTM. https://www.nccn.org/professionals/physician_gls/pdf/cervical_blocks.pdf.
Accessed March 1, 2021.
|
|
21
|
Small W Jr, Bacon MA, Bajaj A, Chuang LT,
Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshikin LR,
Viswanathan AN and Gaffney DK: Cervical cancer: A global health
crisis. Cancer. 123:2404–2412. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yang J, Cai H, Xiao ZX, Wang H and Yang P:
Effect of radiotherapy on the survival of cervical cancer patients:
An analysis based on SEER database. Medicine (Baltimore).
98(e16421)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Quinn MA, Benedet JL, Odicino F,
Maisonneuve P, Beller U, Creasman WT, Heintz AP, Nagan HY and
Pecorelli S: Carcinoma of the cervix uteri. FIGO 26th annual report
on the results of treatment in gynecological cancer. Int J Gynaecol
Obstet. 95 (Suppl 1):S43–S103. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Karlsson J, Dreifaldt A, Mordhorst LB and
Sorbe B: Difference in outcome for cervical cancer patients treated
with or without brachytherapy. Brachytherapy. 16:133–140.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Barraclough LH, Swindell R, Livsey JE,
Hunter RD and Davidson SE: External beam boost for cancer of the
cervix uteri when intracavitary therapy cannot be performed. Int J
Radiat Oncol Biol Phys. 71:772–778. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Matsuura K, Okabe T, Fujita K, Tanimoto H,
Akagi Y and Kagemoto M: Clinical results of external beam
radiotherapy alone with a concomitant boost program or with
conventional fractionation for cervical cancer patients who did not
receive intracavitary brachytherapy. J Radiat Res. 53:900–905.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ito K, Shimizuguchi T and Karasawa K:
Clinical outcomes following conventional external beam radiotherapy
boost in Japanese patients with cervical cancer who are ineligible
for intracavitary brachytherapy. Jpn J Clin Oncol. 49:270–275.
2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Park HC, Shimizu S, Yonesaka A, Tsuchiya
K, Ebina Y, Taguchi H, Katoh N, Kinoshita R, Ishikawa M, Sakuragi N
and Shirato H: High dose three-dimensional conformal boost using
the real-time tumor tracking radiotherapy system in cervical cancer
patients unable to receive intracavitary brachytherapy. Yonsei Med
J. 51:93–99. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Saibishkumar EP, Patel FD, Sharma SC,
Karunanidhi G, Sankar AS and Mallick I: Results of external-beam
radiotherapy alone in invasive cancer of the uterine cervix: A
retrospective analysis. Clin Oncol (R Coll Radiol). 18:46–51.
2006.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yoshida K, Yamazaki H, Kotsuma T, Takenaka
T, Ueda MM, Miyake S, Tsujimoto Y, Masui K, Yoshioka Y, Sumida I,
et al: Simulation analysis of optimized brachytherapy for uterine
cervical cancer: Can we select the best brachytherapy modality
depending on tumor size? Brachytherapy. 15:57–64. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hong JH, Tsai CS, Lai CH, Chang TC, Wang
CC, Chou HH, Lee SP and Hsueh S: Recurrent squamous cell carcinoma
of cervix after definitive radiotherapy. Int J Radiat Oncol Biol
Phys. 60:249–257. 2004.PubMed/NCBI View Article : Google Scholar
|
